(Q51582398)

7 April 2018

title

Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice. (English)

1 reference

7 April 2018

author name string

T Linn

1

1 reference

7 April 2018

K Schneider

2

1 reference

7 April 2018

B Göke

3

1 reference

7 April 2018

K Federlin

4

1 reference

7 April 2018

publication date

1 March 1996

1 reference

7 April 2018

published in

Acta Diabetologica

1 reference

7 April 2018

volume

33

1 reference

7 April 2018

issue

1

1 reference

7 April 2018

page(s)

19-24

1 reference

7 April 2018

https://scigraph.springernature.com/pub.10.1007/bf00571935

exact match

0 references

cites work

Interleukin-1 beta depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism

1 reference

12 December 2020

Defect of the first-phase insulin secretion to glucose stimulation in the perfused pancreas of the nonobese diabetic (NOD) mouse.

1 reference

12 December 2020

International Symposium on Glucagon-Like Peptide-1. Copenhagen, Denmark, May 17-19, 1993. Abstracts

1 reference

12 December 2020

A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated Patients

1 reference

12 December 2020

Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas

1 reference

12 December 2020

Spontaneous glucose intolerance in the progeny of low dose streptozotocin-induced diabetic mice

1 reference

12 December 2020

Signal transduction of the GLP-1-receptor cloned from a human insulinoma

1 reference

12 December 2020

Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases

1 reference

12 December 2020

The enteroinsular axis revisited. A novel role for an incretin

1 reference

12 December 2020

Glucagon-like peptide-I-(7-37) suppresses hyperglycemia in rats.

1 reference

12 December 2020

Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37).

1 reference

12 December 2020

The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects

1 reference

12 December 2020

Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas

1 reference

12 December 2020

Glucagon-like peptide-1(7-36) amide is a new incretin/enterogastrone candidate

1 reference

12 December 2020

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

12 December 2020

Glucagonlike peptide I (7-37) actions on endocrine pancreas

1 reference

12 December 2020

Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor

1 reference

12 December 2020

Role of infiltrating T cells for impaired glucose metabolism in pancreatic islets isolated from non-obese diabetic mice

1 reference

12 December 2020

Detection of the human glucagon-like peptide 1(7-36) amide receptor on insulinoma-derived cell membranes

1 reference

12 December 2020

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

12 December 2020

Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells

1 reference

12 December 2020

New developments in the incretin concept

1 reference

12 December 2020

Elusive proximal signals of beta-cells for insulin secretion

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00571935

1 reference

7 April 2018

1 reference

7 April 2018